Nebulum Technologies — a biomedical imaging startup that specializes in providing 3D tissue imaging services — consists of passionate scientists with fields of technical expertise in bioengineering, optical engineering, and data science. Nebulum Technologies is missioned to develop state-of-the-art tissue clearing, microscopy, and 3D data analysis technologies aiming to provide accurate, rapid, and comprehensive 3D tissue information for basic and clinical research.Traditional 2D image-guided biopsy has yet to reach its technical perfection, thereby resulting in an outcome where precision becomes insufficient in research and clinical practice. Nebulum Technologies reaches an audience of professionals with specializations in neuroscience, optics, cell biology, and electrical engineering to bring to market their unique developments of relevant techniques that possess promising prospective and uniqueness.To bring to patients the most rapid and ideal clinical practice guidelines, examination procedures are carried out by Nebulum Technologies in a systematic approach to obtain a whole array of 3D visual imaging and quantitative information. In the future, the firm will also continue to embark on an effort to offer cancer screening and the relevant clinical services in 3D for substantially improving the precision and accuracy of the clinical examination along with minimizing the technical insufficiency, including the amount of time and expenses spent on the research and development process.